25934-52-5 Usage
Description
3-Cyclopropylmethoxy-4-hydroxybenzaldehyde is an organic compound characterized by the presence of a cyclopropylmethoxy group at the 3-position and a hydroxyl group at the 4-position of a benzene ring. It features a benzaldehyde functional group, which is an aldehyde attached to a benzene ring. 3-Cyclopropylmethoxy-4-hydroxybenzaldehyde is known for its potential applications in various chemical and pharmaceutical processes.
Uses
Used in Pharmaceutical Industry:
3-Cyclopropylmethoxy-4-hydroxybenzaldehyde is used as a reactant in the preparation of ethyl (alkoxy)(cyclopropylmethoxy)-4-hydroxy-3-quinolinecarboxylates. These quinolinecarboxylate derivatives are of interest in the pharmaceutical industry due to their potential as therapeutic agents, particularly in the development of new drugs targeting various diseases and conditions.
In the synthesis of these ethyl (alkoxy)(cyclopropylmethoxy)-4-hydroxy-3-quinolinecarboxylates, 3-cyclopropylmethoxy-4-hydroxybenzaldehyde serves as a key intermediate, contributing to the formation of the desired quinolinecarboxylate structure. The cyclopropylmethoxy group imparts unique properties to the final product, which may enhance its pharmacological activity, selectivity, and bioavailability.
Overall, 3-Cyclopropylmethoxy-4-hydroxybenzaldehyde plays a crucial role in the development of novel pharmaceutical compounds, particularly in the area of quinolinecarboxylate-based drugs, offering potential benefits in the treatment of various medical conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 25934-52-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,5,9,3 and 4 respectively; the second part has 2 digits, 5 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 25934-52:
(7*2)+(6*5)+(5*9)+(4*3)+(3*4)+(2*5)+(1*2)=125
125 % 10 = 5
So 25934-52-5 is a valid CAS Registry Number.
25934-52-5Relevant articles and documents
Novel 3-cyclopropylmethoxy-4-alkoxybenzamide PDE (phosphodiesterase) 4 inhibitors
-
Paragraph 0025, (2016/10/10)
The invention discloses novel 3-cyclopropylmethoxy-4-alkoxybenzamide PDE (phosphodiesterase) 4 inhibitors. The inhibitors are compounds represented in a general formula I or a general formula II, prodrugs thereof, pharmaceutically usable salts thereof or solvates thereof, wherein R is independent methyl (Me-) or difluoromethyl (CF2H-); R is independent H, Me or Et; R is independent H, MeO or Cl; CnH(2n+2) is alkyl, and N is larger than or equal to 2; a substance shown in the specification is a substituted benzene ring or pyridine ring; X is C or N; Y is C or N. The novel 3-cyclopropylmethoxy-4-alkoxybenzamide PDE 4 inhibitors have the advantages of high in-vitro enzyme inhibition activity, capability of selective application to PDE4 and good anti-inflammation effect and anti-depression effect.